Litcius/Paper detail

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

Daniele Marinelli, Marco Mazzotta, Stefano Scalera, Irene Terrenato, Francesca Sperati, Luigi D’Ambrosio, Matteo Pallocca, Giacomo Corleone, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Silvia Carpano, Patrizia Vici, Marco Filetti, Raffaele Giusti, Andrea Vecchione, Mario Occhipinti, Alain Gelibter, Andrea Botticelli, Francesca De Nicola, Ludovica Ciuffreda, Frauke Goeman, Enzo Gallo, Paolo Visca, Edoardo Pescarmona, Maurizio Fanciulli, Ruggero De Maria, Paolo Marchetti, Gennaro Ciliberto, Marcello Maugeri‐Saccà

2020Annals of Oncology223 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunotherapyOncologyAdenocarcinomaInternal medicineLung cancerCohortSurvival analysisCancerCancer researchCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisLung Cancer Treatments and Mutations
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden | Litcius